Dithranol (CAS No 1143-38-0) is a well-known anthracene derivative used primarily in dermatological research due to its anti-inflammatory and antiproliferative properties Originally derived from plant sources this compound acts by targeting mitochondrial pathways inhibiting cell proliferation and inducing apoptosis which are beneficial in treating hyperproliferative skin disorders Its efficacy in vitro is often observed in the nanomolar to low micromolar range making it a potent candidate for various experimental settings Dithranol is frequently utilized in cell culture studies and animal models to explore mechanisms of action in the context of psoriasis and other skin-related conditions It is also valuable in drug screening assays to evaluate potential therapeutic agents Experimental concentrations typically depend on the specific research design ensuring its adaptability across multiple research paradigms